PTCT EBITDA Margin
Ptc Therapeutics Inc · EBITDA Margin
PTCT EBITDA Margin
Latest reported17.20%period ending
PTCT TTM EBITDA Margin (-77.46% → 17.20%)
TTM ebitda margin
High-resolution chart · PNG
PTCT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 17.2009% | |
| -2.5989% | |
| 51.2906% | |
| 51.2482% | |
| 47.6653% | |
| 47.3356% | |
| -14.9313% | |
| -11.7312% | |
| -14.6746% | |
| -27.3807% | |
| -35.2241% | |
| -53.1957% | |
| -51.3078% | |
| -46.7978% | |
| -52.6304% | |
| -48.6276% | |
| -58.5548% | |
| -60.5573% | |
| -68.3609% | |
| -60.118% | |
| -45.6742% | |
| -69.9147% | |
| -79.6001% | |
| -91.8546% | |
| -116.8955% | |
| -71.3393% | |
| -63.2188% | |
| -54.5677% | |
| -54.789% | |
| -46.1356% | |
| -26.2618% | |
| -15.2512% | |
| -7.8802% | |
| -14.1085% | |
| -23.9784% | |
| -57.5714% | |
| -75.1088% | |
| -128.6364% | |
| -154.8661% | |
| -216.3663% | |
| -284.4063% | |
| -344.1628% | |
| -479.1121% | |
| -448.0649% | |
| -554.8275% | |
| -629.3695% | |
| -423.1711% | |
| -542.7194% | |
| -199.0774% | |
| -141.4931% | |
| -137.272% | |
| -92.6731% | |
| -140.4691% | |
| -102.786% | |
| -77.4565% |